Australia markets closed

Addex Therapeutics Ltd (ADDXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.99000.0000 (0.00%)
At close: 10:31AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.76
52-week change 3-36.54%
S&P500 52-week change 3-16.45%
52-week high 31.5600
52-week low 30.9900
50-day moving average 30.9900
200-day moving average 31.0898

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 526.37M
Implied shares outstanding 6N/A
Float 827.41M
% held by insiders 19.16%
% held by institutions 118.60%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,302.76%

Management effectiveness

Return on assets (ttm)-78.64%
Return on equity (ttm)-180.95%

Income statement

Revenue (ttm)1.59M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)-82.60%
Gross profit (ttm)-9.69M
EBITDA -20.84M
Net income avi to common (ttm)-21.07M
Diluted EPS (ttm)-0.5440
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.81M
Total cash per share (mrq)0.23
Total debt (mrq)336.95k
Total debt/equity (mrq)4.91
Current ratio (mrq)2.55
Book value per share (mrq)0.18

Cash flow statement

Operating cash flow (ttm)-16.16M
Levered free cash flow (ttm)-8.47M